Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
暫譯: 乳腺癌中的奈米治療診斷：進展、挑戰與未來展望

Dr. Rishabha Malviya is a Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of interest includes formulation optimization, nano formulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. His name has been included in Word's top 2% scientist list for the years 2020 to 2024.

Dr. Sathvik Belagodu Sridhar is an Associate Dean and Professor at RAK College of Pharmacy, RAK Medical and Health Sciences University, UAE. With 25 years of experience in clinical pharmacy across India, Malaysia, and the UAE, Dr. Sathvik has held key academic roles, including Assistant Professor at JSS College of Pharmacy, Senior Lecturer at International Medical University, Malaysia, and Professor and Chairperson at RAK College of Pharmacy. His research focuses on Medication Safety, Pharmacovigilance, Pharmacoepidemiology, and Renal and Psychiatry Clinical Pharmacy.

Dr. Musarrat Husain Warsi is an Associate Professor at the Department of Pharmaceutics, College of Pharmacy, Taif University, Taif, Saudi Arabia. He is involved in design and development of nano formulations for drugs and herbal ingredients. He is well versed with lipid vesicular carriers, lipid nanoparticles, polymeric nanoparticles, and Nano- emulsions. Dr. Warsi also holds position of Editor-in-chief, in Biological sciences and served as Guest Editor in Pharmaceutics journals.

Dr. Rishabha Malviya 是加爾戈提亞大學醫學與相關科學學院藥學系的教授。他的研究興趣包括配方優化、奈米配方、靶向藥物傳遞、局部藥物傳遞以及天然聚合物作為藥用輔料的特性分析。他的名字被列入2020年至2024年世界前2%科學家名單中。

Dr. Sathvik Belagodu Sridhar 是阿聯酋RAK醫學與健康科學大學RAK藥學院的副院長及教授。擁有25年在印度、馬來西亞和阿聯酋的臨床藥學經驗，Dr. Sathvik曾擔任多個重要學術職位，包括JSS藥學院的助理教授、馬來西亞國際醫科大學的高級講師，以及RAK藥學院的教授和系主任。他的研究重點在於藥物安全、藥物監測、藥物流行病學以及腎臟和精神科臨床藥學。

Dr. Musarrat Husain Warsi 是沙烏地阿拉伯塔伊夫大學藥學院藥劑學系的副教授。他參與藥物和草本成分的奈米配方設計與開發。他對脂質囊泡載體、脂質奈米顆粒、高分子奈米顆粒和奈米乳液非常熟悉。Dr. Warsi還擔任生物科學期刊的主編，並曾擔任藥劑學期刊的客座編輯。